FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > Near term catalysts

<< Previous

Bullboard Posts

Next >>

Comment by JAKPUG4LIFEon Feb 09, 2022 12:17pm

57 Views

Post# 34412934

RE:RE:Near term catalysts

Near term catalysts not just hopes and dreams

FSD Pharma wants to sell their previous cannabis facility for $21M Canadian "Wants" been on market for how long now

$ELYM elium therapeutics has their PEA results due 1st half of 2022 it could be positive or negative catalyst towards FSD Pharma because FSD Also has PEA screw elym, they are not fsd, maybe they should try doing something on their own for once

FSD PEA needs a new indication for a phase 2 clinical trial in the works needs wants and hopes

If they can sell the cobourg facility they can use that to improve their balance sheet once again the balance sheet, only thing they have but never use

Lucid Psych - their major depressive drug candidate which is psychoactive is not yet patented from what i understand
so hope?
Lucid MS - is fully patented not only in USA but also in EUso what a statement next step

Preclinical mouse models in auto immune multiple sclerosis has shown to restore the limbs of the mice.great for the mice, near term for fsd?? again just hope or pump??

Lucid MS needs to start IND and or phase 1 clinical trialsneeds again the key word as has been for the last 2 failed phases later 2022 or 2023 near term ???

Thank you

Mil_Man54 wrote: So nothing then...just ifs and maybes and hopefullies....I mean look at your first statement Rosenberg...I want to have the winning lottery ticket....your statement has no merit...in fact...my statement has a better chance of coming true that them selling that plant for $21M....you post fluff and no substance....and turn a blind eye to reality....pumper 101....

DavidRosenberg wrote: FSD Pharma wants to sell their previous cannabis facility for $21M Canadian

$ELYM elium therapeutics has their PEA results due 1st half of 2022 it could be positive or negative catalyst towards FSD Pharma because FSD Also has PEA

FSD PEA needs a new indication for a phase 2 clinical trial in the works

If they can sell the cobourg facility they can use that to improve their balance sheet

Lucid Psych - their major depressive drug candidate which is psychoactive is not yet patented from what i understand

Lucid MS - is fully patented not only in USA but also in EU

Preclinical mouse models in auto immune multiple sclerosis has shown to restore the limbs of the mice.

Lucid MS needs to start IND and or phase 1 clinical trials

Thank you